Showing results (1-10 of 337) with videos related to
Sort By:
Pageof 34
Biomarkers in Medicine|September 4, 2015
Therapeutic drug monitoring of targeted anticancer therapyLaurent A Decosterd, Nicolas Widmer, Khalil Zaman, et al.Clinical Pharmacokinetics|October 7, 2010
Oseltamivir in seasonal, avian H5N1 and pandemic 2009 A/H1N1 influenza: pharmacokinetic and pharmacodynamic characteristicsNicolas Widmer, Pascal Meylan, Anton Ivanyuk, et al.Blood|September 3, 2010
Drug interactions with the tyrosine kinase inhibitors imatinib, dasatinib, and nilotinibAmina Haouala, Nicolas Widmer, Michel A Duchosal, et al.Frontiers in Pharmacology|March 21, 2020
The Steps to Therapeutic Drug Monitoring: A Structured Approach Illustrated With ImatinibThierry Buclin, Yann Thoma, Nicolas Widmer, et al.Drug Metabolism Letters|May 8, 2010
siRNA-mediated knock-down of P-glycoprotein expression reveals distinct cellular disposition of anticancer tyrosine kinases inhibitorsAmina Haouala, Holger Rumpold, Gerold Untergasser, et al.Clinical Pharmacokinetics|February 21, 2012
Therapeutic drug monitoring of imatinib: Bayesian and alternative methods to predict trough levelsVerena Gotta, Nicolas Widmer, Michael Montemurro, et al.Journal of Pharmaceutical and Biomedical Analysis|July 20, 2018
Comparison against current standards of a DNA aptamer for the label-free quantification of tobramycin in human sera employed for therapeutic drug monitoringEnrico Tenaglia, Anna Ferretti, Laurent A Decosterd, et al.Therapeutic Drug Monitoring|June 17, 2006
Are plasma levels valid surrogates for cellular concentrations of antiretroviral drugs in HIV-infected patients?Sara Colombo, Amalio Telenti, Thierry Buclin, et al.Therapeutic Drug Monitoring|September 4, 2019
Therapeutic Drug Monitoring of Targeted Anticancer Protein Kinase Inhibitors in Routine Clinical Use: A Critical ReviewEvelina Cardoso, Monia Guidi, Benoît Blanchet, et al.Revue Medicale Suisse|September 5, 2008
[Principles of therapeutic drug monitoring]Nicolas Widmer, Chantal Csajka, Dominique Werner, et al.Pageof 34